VEDOLIZUMAB, USTEKINUMAB AND TOFACITINIB AS TRIPLE THERAPY FOR ULCERATIVE COLITIS

被引：0
|
作者：
Thurston, Theresa
Moskow, Joshua
Glassner, Kerri
Abraham, Bincy
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S104 / S104
页数：1
相关论文
共 50 条
  • [21] Tofacitinib Effectiveness and Safety as Therapy for Ulcerative Colitis
    McNally, M.
    Keating, E.
    Gray, E.
    McCormick, E.
    Carroll, A.
    Palmer, C.
    Kennedy, U.
    McKiernan, S.
    MacCarthy, F.
    Dunne, C.
    Hartery, K.
    Egan, L.
    Slattery, E.
    Ryan, B.
    McNamara, D.
    O'Connor, A.
    Breslin, N.
    O'Donnell, S.
    Cullen, G.
    Mulcahy, H.
    Sheridan, J.
    Doherty, G.
    Kevans, D.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I431 - I431
  • [22] Tofacitinib Effectiveness and Safety as Therapy for Ulcerative Colitis
    McNally, M.
    Keating, E.
    Gray, E.
    McCormick, E.
    Carroll, A.
    Palmer, C.
    Kennedy, U.
    McKiernan, S.
    MacCarthy, F.
    Dunne, C.
    Hartery, K.
    Egan, L.
    Slattery, E.
    Ryan, B.
    McNamara, D.
    O'Connor, A.
    Breslin, N.
    O'Donnell, S.
    Cullen, G.
    Mulcahy, H.
    Sheridan, J.
    Doherty, G.
    Kevans, D.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I431 - I431
  • [23] Tofacitinib as a Rescue Therapy for Ulcerative Colitis in Pregnancy
    Rowan, Catherine
    Yeaman, Fiona
    Ernest-Suarez, Kenneth
    Martin, Marie-Louise
    Panaccione, Remo
    Shukla, Tushar
    Grossi, Matt
    Vlasschaert, Meghan
    Novak, Kerri
    Seow, Cynthia
    INFLAMMATORY BOWEL DISEASES, 2024, 30 (05) : 868 - 870
  • [24] Comparison of Colectomy Rates in Biologic Naive Ulcerative Colitis Patients on Ustekinumab and Vedolizumab
    Mohammed, Abdul
    Alchirazi, Khaled Alsabbagh
    Eltelbany, Ahmed
    Hamid, Osama
    Gonzaga, Ernesto Robalino
    Garg, Rajat
    Paranji, Neethi
    Singh, Amandeep
    Kais, Susan
    Regueiro, Miguel
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S755 - S756
  • [25] Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study
    Allocca, Mariangela
    Catalano, Gaia
    Savarino, Edoardo V.
    Chaparro, Maria
    Levartovsky, Asaf
    Michalopoulos, George
    Viazis, Nikos
    Fousekis, Fotis S.
    Psistakis, Andreas
    Noviello, Daniele
    do Nascimento, Catarina Neto
    Caron, Benedicte
    Kitsou, Vassiliki
    Bamias, Giorgos
    Garcia, Maria Jose
    Zacharopoulou, Eirini
    Foteinogiannopoulou, Kalliopi
    D'Amico, Ferdinando
    Koutroubakis, Ioannis
    Ellul, Pierre
    Tzouvala, Maria
    Peyrin-Biroulet, Laurent
    Torres, Joana
    Caprioli, Flavio
    Karmiris, Konstantinos
    Theodoropoulou, Angeliki
    Katsanos, Konstantinos H.
    Christodoulou, Dimitrios K.
    Mantzaris, Gerassimos J.
    Kopylov, Uri
    Gisbert, Javier P.
    Danese, Silvio
    Magro, Fernando
    Carla, Fornari
    Fiorino, Gionata
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2024, 12 (05) : 543 - 551
  • [26] Tofacitinib for ulcerative colitis
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (07): : 475 - 475
  • [27] Tofacitinib in ulcerative colitis
    Archer, Thomas P.
    Moran, Gordon W.
    Ghosh, Subrata
    IMMUNOTHERAPY, 2016, 8 (05) : 495 - 502
  • [28] Vancomycin and Ustekinumab Combination Therapy in Acute Ulcerative Colitis
    Nguyen, Khue M.
    Wright, Emily K.
    ACG CASE REPORTS JOURNAL, 2024, 11 (03)
  • [29] Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis REPLY
    Sands, Bruce E.
    Marano, Colleen
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (01): : 91 - 91
  • [30] Tofacitinib induction therapy in ulcerative colitis can be prolonged
    Di Lellis, Maddalena Angela
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, 60 (12): : 1742 - +
12345